CellReady: Our roots in Cell Therapy
Cell Easy’s story is rooted in the heart of research, and this invaluable experience shapes every action we take to help you bring life-saving treatments forward. Our story started with ASCs. They are remarkable cells, recognized for their natural ability to regenerate tissue, modulate immune responses, and support repair processes. While early autologous trials demonstrated their potential, treating one patient at a time was neither sustainable nor scalable. To efficiently reach more patients, we transformed the autologous process into an allogeneic one and created CellReady, our proprietary GMP-grade allogeneic ASC platform. This platform enables standardized, regulatory-compliant, and cost-controlled manufacturing of MSCs.
Key Numbers
x20
Cost reduction vs autologous process
3,5.109
Cells per batch
25
Analytical parameters screened
Why CellReady makes the difference
Our process is based on a xeno-free, scalable, andGMP-compliant manufacturing framework, with a focus on consistency and clinical applicability. Our production process is both shorter in time (14 days), therefore reducing the number of passages of these cells and more efficient in terms of the number of cells obtained and their quality than that used in other studies conducted in the same field. This reduction in cell amplification preserves the immunomodulatory properties of native cells as much as possible while limiting the drift associated with culture processes.
Clinical Programs using CellReady
In collaboration with CHU Toulouse, our Adipose derived MSCs are applied across five clinical programs:
MSC Expertise & Ready-to-Use Cells
We provide adipose-derived MSCs (RUO and GMP) together with end-to-end expertise to support industrial-scale manufacturing, preclinical development, and clinical translation. Donor qualification and characterization ensure safety, reproducibility, and robust biological performance.
We also generate extensive preclinical data, including toxicity and tumorigenicity studies in relevant mouse models, and perform an in-depth analytical assessment covering safety, identity, and potency across more than 25 critical parameters.
We deliver customized GMP batches to enable rapid access to industrial quantities of MSCs, suitable for downstream uses such as engineered or native drug products, starting or intermediate cell banks, exosome production, or cellular cargo and meatable applications.
Discover more about Cell Easy
Cell Easy
News
Let’s talk about your project
Let’s turn your vision into a reality.
Phone: +33 534 276 550
Address: Cell-Easy SAS, 4 bis avenue Hubert Curien,
31100 Toulouse, France
Mail: info@cell-easy.com
